Selected article for: "antiviral immunity and immune response"

Author: Bloom, Kristie; Maepa, Mohube Betty; Ely, Abdullah; Arbuthnot, Patrick
Title: Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
  • Document date: 2018_4_12
  • ID: 0dr9eans_21
    Snippet: Reconstituting the cytotoxic T-cell response against HBV holds great promise as a strategy for the immune-mediated clearance of the virus in chronic carriers. While engineered T-cells with chimeric T-cell receptors against HBV antigens have been developed, investigations are yet to progress beyond preclinical development of the technology [101] [102] [103] [104] [105] . DNA vaccines have the potential to induce strong antibody and T-cell-mediated.....
    Document: Reconstituting the cytotoxic T-cell response against HBV holds great promise as a strategy for the immune-mediated clearance of the virus in chronic carriers. While engineered T-cells with chimeric T-cell receptors against HBV antigens have been developed, investigations are yet to progress beyond preclinical development of the technology [101] [102] [103] [104] [105] . DNA vaccines have the potential to induce strong antibody and T-cell-mediated immune responses and thereby clear chronic HBV infections (reviewed by [106] ). While studies exploring this strategy are few, inducing strong antiviral immunity with therapeutic vaccines in conjunction with cytokine-mediated stimulation of an immune response undoubtedly has potential for management of chronic hepatitis B.

    Search related documents:
    Co phrase search for related documents
    • antiviral immunity and chronic HBV infection: 1, 2
    • antiviral immunity and chronic hepatitis: 1, 2, 3, 4
    • antiviral immunity and dna vaccine: 1, 2
    • antiviral immunity and great promise: 1
    • antiviral immunity and HBV antigen: 1
    • antiviral immunity and HBV infection: 1, 2, 3
    • antiviral immunity and immune mediate: 1, 2
    • antiviral immunity and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell mediate and cytokine mediate: 1
    • cell mediate and dna vaccine: 1
    • cell mediate and immune mediate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cell mediate and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • chronic carrier and HBV infection: 1, 2, 3
    • chronic HBV infection and dna vaccine: 1
    • chronic HBV infection and HBV antigen: 1, 2, 3, 4, 5, 6, 7, 8
    • chronic HBV infection and HBV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic HBV infection and immune response: 1, 2, 3, 4, 5, 6, 7
    • chronic hepatitis and dna vaccine: 1
    • chronic hepatitis and HBV antigen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12